Why the U.K. is seeing an uptick in COVID-19 cases


The United Kingdom is experiencing an uptick in coronavirus cases. It's "tiny" compared to previous spikes, David Leonhardt writes in The New York Times, but he adds that the country will still be "important to watch" in the next few weeks. So, considering the U.K. has had a mostly successful vaccine rollout, why is the increase happening?
The primary culprit is likely the more transmissible Delta variant, first identified in India, that's been spreading in the U.K. The good news is that it appears vaccines hold up pretty well against the mutatated virus, but less so for people who have received only one vaccine dose, which is more common in the U.K. than it is in the United States. The U.K. chose to prioritize first shots early in the rollout, which allowed a wider swath of people to get at least some protection. That was "not necessarily" a mistake, despite the Delta variant changing the game a bit, Leonhardt writes, but it does mean more people — especially younger people who are still in the middle of the vaccination process — have a higher risk of getting infected. Fortunately, about 90 percent of U.K. residents older than 65 have received both doses, and the country "is accelerating second shots for vulnerable people" now, Leonhardt writes.
Dr. Monica Gandhi, who specializes in infectious diseases at the University of California, San Francisco, also pointed out that the U.K. "does a lot of asymptomatic testing" even among the vaccinated population, which may play a role in the increase in cases and help explain why, for now at least, they aren't accompanied by rises in hospitalizations and deaths.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
June 28 editorial cartoons
Cartoons Saturday's political cartoons include stupid wars, a critical media, and mask standards
-
Thai fish pie with crispy turmeric potatoes recipe
The Week Recommends Tasty twist on the Lancashire hot pot is given a golden glow
-
Palestine Action: protesters or terrorists?
Talking Point Damaging RAF equipment at Brize Norton blurs line between activism and sabotage, but proscription is a drastic step
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths